513 results on '"Paietta, E"'
Search Results
2. Shorter long-term post-transplant life expectancy may be due to prior chemotherapy for the underlying disease: analysis of 3012 patients with acute myeloid leukemia enrolled on 9 consecutive ECOG-ACRIN trials
3. Erk Negative Feedback Control Enables Pre-B Cell Transformation and Represents a Therapeutic Target in Acute Lymphoblastic Leukemia
4. Identification of FOXM1 as a therapeutic target in B-cell lineage acute lymphoblastic leukaemia
5. The evolving role of chemotherapy and hematopoietic cell transplants in Ph-positive acute lymphoblastic leukemia in adults
6. Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499
7. Treatment of Poor Prognosis AML Patients Using PSC833 (Valspodar) Plus Mitoxantrone, Etoposide, and Cytarabine (PSC-MEC)
8. Effect of genetic profiling on prediction of therapeutic resistance and survival in adult acute myeloid leukemia
9. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition
10. Treatment of Poor Prognosis Acute Myelogenous Leukemia with PSC-833 and Mitoxantrone, Etoposide, Cytarabine
11. Very late relapse of AML after allogeneic hematopoietic cell transplantation is often extramedullary
12. Cytomorphology and Clinical Outcome in 80 Patients with AML M4Eo and Inversion 16
13. Incidence of Infections in Adult Patients (> 55 Years) with Acute Myeloid Leukemia Treated with Yeast-Derived GM-CSF (Sargramostim): Results of a Double-Blind Prospective Study by the Eastern Cooperative Oncology Group
14. Evaluation of In Vivo Natural Killer and Lymphokine-Activated Killer Cell Activity in Patients Treated with High-Dose Interleukin-2 and Adoptive Transfer of Autologous LAK Cells
15. PHF6 mutations in adult acute myeloid leukemia
16. Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998)
17. Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide
18. Low expression of the myeloid differentiation antigen CD65s, a feature of poorly differentiated AML in older adults: study of 711 patients enrolled in ECOG trials
19. Assessing minimal residual disease (MRD) in leukemia: a changing definition and concept?
20. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience
21. Phase II study of carboplatin in blast crisis of chronic myeloid leukemia: Eastern Cooperative Oncology Group Study E1992
22. Mutational analysis of candidate tumor-associated genes in acute megakaryoblastic leukemia
23. Expression of CD25 (interleukin-2 receptor α chain) in adult acute lymphoblastic leukemia predicts for the presence of BCR/ABL fusion transcripts: results of a preliminary laboratory analysis of ECOG/MRC Intergroup Study E2993
24. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukaemia: 1
25. Effects of all‐trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia
26. Treatment of Poor Prognosis AML Patients Using PSC833 (Valspodar) Plus Mitoxantrone, Etoposide, and Cytarabine (PSC-MEC)
27. Cytomorphology and Clinical Outcome in 80 Patients with AML M4Eo and Inversion 16
28. Incidence of Infections in Adult Patients (> 55 Years) with Acute Myeloid Leukemia Treated with Yeast-Derived GM-CSF (Sargramostim): Results of a Double-Blind Prospective Study by the Eastern Cooperative Oncology Group
29. Survival After Phase II Treatment of Advanced Renal Cell Carcinoma with Taxol or High-Dose Interleukin-2
30. Energy demand hourly simulations and energy saving strategies in greenhouses for the Mediterranean climate
31. A Marker and Putative Pathoantigen of Hodgkin’s Cells
32. Short-Term In Vitro Sensitivity Testing in Acute Leukemia
33. Rekonstitution der hormonellen Stimulierbarkeit β-rezeptordefekter Fibroblasten durch Fusion mit S-49-Lymphomzellen
34. In vitro-Sensitivitätstestung leukämischer Zellen gegenüber Etoposid und anderen zytostatischen Substanzen
35. Effect of Phosphodiesterase-Inhibition on Smooth Muscle Tone
36. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia
37. Outcome in Philadelphia Chromosome Positive (Ph plus ) Adult ALL Patients (Pts) May Be More Determined by CD25 Expression Than by Ph Status Per Se
38. Outcome of 1,229 Adult Philadelphia Chromosome Negative B Acute Lyrnphoblastic Leukemia (B ALL) Patients (pts) From the International UKALLXII/E2993 Trial No Difference In Results Between B Cell Immuno phenotypic Subgroups
39. Energy demand hourly simulations and energy saving strategies in greenhouses for the Mediterranean climate
40. DNMT3A haploinsufficiency transforms FLT3ITD myeloproliferative disease into a rapid, spontaneous, and fully penetrant acute myeloid leukemia
41. Mantle cell lymphoma initial therapy with abbreviated R-CHOP followed by 90Y-ibritumomab tiuxetan: 10-year follow-up of the phase 2 ECOG-ACRIN study E1499
42. Chronisch lymphatische Leukämie vom B-Zellen-Typ: Klinische und morphologische Untersuchungen zur diagnostischen Abgrenzung
43. Investigations on karyotype evolution in patients with chronic myeloid leukemia (CML)
44. Evaluation of natural killer and lymphokine-activated killer (LAK) cell activity in vivo in patients treated with high-dose interleukin-2 and adoptive transfer of autologous LAK cells
45. Integrative Genome Wide DNA Methylation and Gene Expression Analysis Reveals Biological and Clinical Insights In Adult Acute Lymphoblastic Leukemia
46. PHF6 mutations in T-cell lymphoblastic leukemia
47. A Marker and Putative Pathoantigen of Hodgkin’s Cells
48. Short-Term In Vitro Sensitivity Testing in Acute Leukemia
49. Plasma cell leukemia with an unusual karyotype and prolonged survival with oral alkylating agent therapy
50. Plasma cell leukemia with an unusual karyotype and prolonged survival following oral alkylating agent therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.